Farther Finance Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.29K | Sell |
31
-49
| -61% | -$5.2K | ﹤0.01% | 3519 |
|
|
2025
Q1 | $10K | Sell |
80
-40
| -33% | -$5K | ﹤0.01% | 2733 |
|
|
2024
Q4 | $14.8K | Buy |
120
+51
| +74% | +$6.28K | ﹤0.01% | 2215 |
|
|
2024
Q3 | $7.69K | Sell |
69
-4
| -5% | -$446 | ﹤0.01% | 2465 |
|
|
2024
Q2 | $7.77K | Buy |
73
+53
| +265% | +$5.64K | ﹤0.01% | 2177 |
|
|
2024
Q1 | $2.38K | Sell |
20
-27
| -57% | -$3.21K | ﹤0.01% | 2416 |
|
|
2023
Q4 | $5.78K | Buy |
47
+10
| +27% | +$1.23K | ﹤0.01% | 1891 |
|
|
2023
Q3 | $4.79K | Buy |
37
+8
| +28% | +$1.04K | ﹤0.01% | 1530 |
|
|
2023
Q2 | $3.6K | Buy |
29
+3
| +12% | +$372 | ﹤0.01% | 1549 |
|
|
2023
Q1 | $3.81K | Buy |
26
+2
| +8% | +$293 | ﹤0.01% | 1423 |
|
|
2022
Q4 | $3.82K | Buy |
+24
| New | +$3.82K | ﹤0.01% | 1258 |
|